Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyÖrebro Univ, Sweden; Spanish Antiphospholipid Syndrome Assoc SAF Espana, Spain.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Univ Crete, Greece; Inst Mol Biol & Biotechnol, Greece.
EULAR Young PARE, Italy.
Carol Davila Univ Med & Pharm, Romania.
ULS Santa Maria, Portugal; Univ Lisbon, Portugal.
Univ Barcelona, Spain.
Hop Cochin, France; Univ Paris Cite, France.
Erasmus MC, Netherlands.
Guys & St Thomas Fdn Trust, England.
NHS Fdn Trust, England.
ULS Santa Maria, Portugal; Univ Lisbon, Portugal.
Sigmund Freud Private Univ, Austria.
Cantonal Hosp St Gallen, Switzerland; Univ Bern, Switzerland.
UCL, England.
UCL, England.
Norwegian Univ Sci & Technol, Norway; Alesund Hosp, Norway.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Royal Wolverhampton Hosp NHS Trust, England; Univ Manchester, England.
Trondheim Reg & Univ Hosp, Norway.
Rigshosp, Denmark.
Rigshosp, Denmark.
German Rheumatol Res Ctr, Germany; Charite Univ Med Berlin, Germany.
Univ Paris Cite, France.
Our Ladys Hosp & Care Serv, Ireland.
Univ Pisa, Italy.
Guys & St Thomas Fdn Trust, England.
Erasmus MC, Netherlands.
Univ Hosp Bern, Switzerland.
Rigshosp, Denmark; Univ Southern Denmark, Denmark.
Zucker Sch Med Hofstra Northwell, NY USA; Rockefeller Univ, NY USA; Hadassah Hebrew Univ, Israel; Hebrew Univ Jerusalem, Israel.
Univ Turin, Italy.
German Rheumatol Res Ctr, Germany; Charite Univ Med Berlin, Germany.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Natl & Kapodistrian Univ Athens, Greece.
ASST Spedali Civili, Italy; Univ Brescia, Italy.
Aarhus Univ Hosp, Denmark; Aarhus Univ, Denmark.
Univ Nis, Serbia.
Odense Univ Hosp, Denmark.
Norwegian Univ Sci & Technol, Norway.
Lupus Europe, Belgium.
Danish Hosp Rheumat Dis, Denmark; Southern Danish Univ, Denmark; ASST Spedali Civili, Italy.
Show others and affiliations
2025 (English)In: Therapeutic Advances in Musculoskeletal Disease, ISSN 1759-7218, E-ISSN 1759-720X, Vol. 17, article id 1759720X251350087Article in journal (Refereed) Published
Abstract [en]
Background: Treating rheumatic musculoskeletal diseases (RMDs) during pregnancy and breastfeeding presents significant complexities, mainly due to inconsistencies between the clinical guidance documents and the reference safety information, including the summary of product characteristics (SmPC) and the patient information leaflets (PIL).Objectives: To assess healthcare professionals' (HCPs) prescribing behaviors, comfort levels, and challenges when advising patients, focusing on discrepancies between clinical guidance documents and SmPC/PIL.Design: Online survey entitled PRAISE (Perception of healthcare providers Regarding Antirheumatics in pregnancy and breastfeeding: advice, Information and patient perSpEctives) and disseminated through HCPs groups and social media.Methods: A cross-sectional survey was conducted among 414 HCPs globally. Respondents were divided into prescribers (n = 336) and non-prescribers (n = 78) based on their self-reported role in prescribing antirheumatic medications to pregnant or breastfeeding patients with RMDs. The survey covered demographics, clinical experience, confidence in prescribing, use of clinical guidelines, and experiences managing conflicting information between guidelines and SmPC/PIL.Results: Prescribers were more likely than non-prescribers to feel comfortable discussing medication safety during pregnancy. Most prescribers found clinical guidance documents useful, with 48% rating them as "very useful" and 38% as "extremely useful." In case of conflicting information between clinical guidance documents and SmPC/PIL, 58% of HCPs reported that it caused confusion and tension in patient-doctor relationships, and almost 20% of them are "likely" or "very likely" to discontinue ongoing treatment. Clear communication and shared decision-making were the most common strategies used to address patient concerns.Conclusion: HCPs often face significant challenges when advising patients with RMDs on the use of medications during pregnancy and breastfeeding. Conflicting information between clinical guidance documents and SmPC/PIL can disrupt patient-doctor relationship and lead to treatment discontinuation, with potential consequences on maternal disease control. Improved alignment between clinical guidance documents and the SmPC/PIL could enhance patient care and prevent confusion among HCPs and patients.
Place, publisher, year, edition, pages
SAGE PUBLICATIONS LTD , 2025. Vol. 17, article id 1759720X251350087
Keywords [en]
antirheumatic medications; breastfeeding; lactation; patient information leaflet; pregnancy; summary of product characteristics
National Category
Social and Clinical Pharmacy
Identifiers
URN: urn:nbn:se:liu:diva-216921DOI: 10.1177/1759720X251350087ISI: 001529720900001PubMedID: 40678818OAI: oai:DiVA.org:liu-216921DiVA, id: diva2:1992694
Note
Funding Agencies|Study Group on Reproductive Health and Family Planning; Centre of Expertise in Rheumatology
2025-08-282025-08-282025-10-07